(Q37783289)

23 August 2017

title

Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion (English)

1 reference

23 August 2017

1 reference

4

Mark F Munsell

1 reference

23 August 2017

Norman Jaffe

2

1 reference

23 August 2017

Jean-Bernard Durand

3

1 reference

23 August 2017

Winston W. Huh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795769

2 July 2024

Cynthia E. Herzog

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20795769

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20795769

2 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/08880018.2010.503335

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Pediatric Hematology and Oncology

2 July 2024

published in

1 reference

23 August 2017

volume

27

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

546-557

1 reference

Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS).

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Recent advances in the prevention of anthracycline cardiotoxicity in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Cardiac toxicity of antineoplastic anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Pathogenesis of cardiotoxicity induced by anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2010.503335

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers

2 July 2024

10

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

2 July 2024

13

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

2 July 2024

15

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

2 July 2024

16

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

2 July 2024

17

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

2 July 2024

20

1 reference

https://api.crossref.org/works/10.3109/08880018.2010.503335

2 July 2024

Identifiers

1 reference

release_rttfx6fsabd55a6hugo47fy35m

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rttfx6fsabd55a6hugo47fy35m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference